| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
3e-08 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
9e-08 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
1e-07 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
| mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-06 |